Summary
Matthew Berman interviews OpenAI CEO Sam Altman in a wide-ranging conversation about where AI is headed. Altman discusses OpenAI’s recent announcements of math proofs and new discoveries, arguing AI is entering an era of generating significant new knowledge that could extend to biology, materials science, and energy. Altman hopes for a candidate treatment for a major disease within the next couple of years, while noting the FDA process will take time.
The discussion compares mathematicians’ reaction to AI with how software engineers first reacted to AI coding. Altman says demand for software turned out far larger than expected, though it is unclear whether the same holds for math. Other topics include recursive self-improvement (RSI) and the risks of labs racing to push it, compute constraints, and the view that AI needs a new device form factor.
Altman also argues society should aim for a new Renaissance rather than a new industrial revolution, addresses whether inequality will widen, and says they do not believe today’s models are conscious, while acknowledging how hard the question is. The interview is useful for anyone tracking OpenAI’s direction and the wider debate over AI’s economic and social impact.
📺 Source: Matthew Berman · Published October 21, 2026
🏷️ Format: Interview
